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Abstract
Background: Posttraumatic osteoarthritis can develop after an intra-articular extremity fracture, leading to pain and
loss of function. According to international guidelines, anatomical reduction and fixation are the basis for an
optimal functional result. In order to achieve this during fracture surgery, an optimal view on the position of the
bone fragments and fixation material is a necessity. The currently used 2D-fluoroscopy does not provide sufficient
insight, in particular in cases with complex anatomy or subtle injury, and even an 18-26% suboptimal fracture
reduction is reported for the ankle and foot. More intra-operative information is therefore needed.
Recently the 3D-RX-system was developed, which provides conventional 2D-fluoroscopic images as well as a 3D-
reconstruction of bony structures. This modality provides more information, which consequently leads to extra
corrections in 18-30% of the fracture operations. However, the effect of the extra corrections on the quality of the
anatomical fracture reduction and fixation as well as on patient relevant outcomes has never been investigated.
The objective of this study protocol is to investigate the effectiveness of the intra-operative use of the 3D-RX-
system as compared to the conventional 2D-fluoroscopy in patients with traumatic intra-articular fractures of the
wrist, ankle and calcaneus. The effectiveness will be assessed in two different areas: 1) the quality of fracture
reduction and fixation, based on the current golden standard, Computed Tomography. 2) The patient-relevant
outcomes like functional outcome range of motion and pain. In addition, the diagnostic accuracy of the 3D-RX-
scan will be determined in a clinical setting and a cost-effectiveness as well as a cost-utility analysis will be
performed.
Methods/design: In this protocol for an international multicenter randomized clinical trial, adult patients (age > 17
years) with a traumatic intra-articular fracture of the wrist, ankle or calcaneus eligible for surgery will be subjected
to additional intra-operative 3D-RX. In half of the patients the surgeon will be blinded to these results, in the other
half the surgeon may use the 3D-RX results to further optimize fracture reduction. In both randomization groups a
CT-scan will be performed postoperatively. Based on these CT-scans the quality of fracture reduction and fixation
will be determined. During the follow-up visits after hospital discharge at 6 and 12 weeks and 1 year
postoperatively the patient relevant outcomes will be determined by joint specific, health economic and quality of
life questionnaires. In addition a follow up study will be performed to determine the patient relevant outcomes
and prevalence of posttraumatic osteoarthritis at 2 and 5 years postoperatively.
Discussion: The results of the study will provide more information on the effectiveness of the intra-operative use
of 3D-imaging during surgical treatment of intra-articular fractures of the wrist, ankle and calcaneus. A randomized
design in which patients will be allocated to a treatment arm during surgery will be used because of its high
* Correspondence: M.S.Beerekamp@amc.nl
1Trauma Unit, Department of Surgery, Academic Medical Center, Amsterdam,
the Netherlands
Full list of author information is available at the end of the article
Beerekamp et al. BMC Musculoskeletal Disorders 2011, 12:151
http://www.biomedcentral.com/1471-2474/12/151
© 2011 the project group of the EF3X-trial et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms
of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.methodological quality and the ability to detect incongruences in the reduction and/or fixation that occur intra-
operatively in the blinded arm of the 3D-RX. An alternative, pragmatic design could be to randomize before the
start of the surgery, then two surgical strategies would be compared. This resembles clinical practice better, but
introduces more bias and does not allow the assessment of incongruences that would have been detected by 3D-
RX in the blinded arm.
Trial registration: Dutch Trial Register NTR 1902
Keywords: Fracture, Wrist, Ankle, Calcaneus, Intra-operative imaging, 2D-fluoroscopy, 3D-imaging, Conebeam-CT,
3D-RX
Background
Fractures of the extremities are common injuries, with
an incidence of 38 wrist fractures per 10,000 inhabitants
per year,[1] and an estimate of 25,000 - 68,000 ankle
fractures per year in the Netherlands [2]. Posttraumatic
osteoarthritis can develop after an intra-articular extre-
mity fracture, which can lead to pain and loss of func-
tion. According to international guidelines anatomical
reduction and fixation are the basis for an optimal func-
tional result [3]. This can be achieved by closed reduc-
tion and cast fixation. If a conservative treatment leads
to a suboptimal reduction and fixation, surgical treat-
ment is indicated.
During open reduction and internal fixation (ORIF)
conventional 2D-fluoroscopy is used to gain more
insight in the fracture fragments and fixation material
next to a direct view. When it involves complex anat-
omy or subtle injury 2D-fluoroscopy often underesti-
mates the extent of the injury or the degree of
displacement of fracture fragments, which can be mis-
leading to the surgeon. Consequently, postoperative X-
ray images and CT-scans frequently show incorrect
positioned screws or incongruences, like gaps and step-
offs, in the joint surface, while these were not recog-
nized on the intra-operative 2D-fluoroscopic images. E.
g. for the ankle and foot even an 18-26% suboptimal
fracture reduction is reported[ 4 - 6 ] .M o r ei n t r a - o p e r a -
tive information is therefore needed in order to mini-
mize suboptimal fracture reduction.
Recently a 3-Dimensional Rotational X-ray system
(3D-RX-system) was developed which can provide more
detailed imaging intra-operatively. This system consists
of a mobile C-arm unit modified to provide a motorized
rotational movement and is combined with a worksta-
tion. Next to conventional 2D-fluoroscopy this system
can provide multiplanar 3-dimensional reconstruction of
the osseous structures.
Several cadaveric studies have been performed on dif-
ferent joints of the upper and lower limb to evaluate the
image quality of intra-operative 3D-imaging [7-12]. In
these studies 3D-imaging had a better diagnostic value
than conventional radiography and 2D-fluoroscopic
images. Although the subjective imaging quality was
higher in CT-scanning, images of the intra-operative
3D-imaging were comparable in diagnostic value. In
addition, in some clinical studies concerning intra-
operative 3D-imaging, this modality has shown to pro-
vide extra information. Extra corrections after 3D-ima-
ging were performed in 11-30% of the fracture
operations [11,13-17]. These corrections concerned sub-
optimal fracture reduction, like intra-articular steps-offs
and fracture gaps, and incorrectly positioned fixation
material.
The studies mentioned above have shown that intra-
operative 3D-imaging provides additional information
and allows the surgeon to recognize problems with frac-
ture reduction and/or fixation during the operation.
However, these studies used indirect measurements to
establish the added value of intra-operative 3D-imaging.
The direct effects on the quality of fracture reduction
and fixation and patient relevant outcomes have not yet
been investigated.
The aim of this protocol for a randomized clinical trial
is to investigate the effectiveness of the the intra-opera-
tive use of the 3D-RX-system as compared to the use of
conventional 2D-fluoroscopy alone in patients with trau-
matic intra-articular fractures of the wrist, ankle and
calcaneus. This effectiveness will be assessed in two dif-
f e r e n ta r e a s :1 )t h eq u a l i t yo ff r a c t u r er e d u c t i o na n d
fixation, based on the current golden standard, Com-
puted Tomography. 2) The patient-relevant outcomes
like functional outcome, range of motion and pain. In
addition, the diagnostic accuracy of the 3D-RX-scan will
be determined in a clinical setting and a cost-effective-
ness as well as a cost-utility analysis will be performed.
Choice for the study design
With this study we aim to address multiple issues
regarding the intra-operative use of 3D-imaging in frac-
tures of the extremities; the diagnostic value (sensitivity
and specificity) of the 3D-RX-scan in a clinical setting,
the therapeutical outcome and its effect on the quality
of fracture reduction and fixation and the patient rele-
vant outcomes. For this purpose we prefer a blinded
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i n v e s t i g a t et h ee f f e c to ft h ei n t r a - o p e r a t i v eu s eo f3 D -
imaging. In order to compare both techniques, patients
will be randomized during surgery after the definitive
adjustments on the basis of 2D-fluoroscopy and before
3D-fluoroscopy. This avoids the phenomenon that the
surgeon neglects the 2D-fluoroscopy and relies on the
envisioned 3D-images for the reduction and fixation
later during the surgical procedure. An additional
advantage of this design is that both the diagnostic
value as well as the effects on the quality of fracture
reduction and fixation can be investigated.
Ad i s a d v a n t a g eo fo u rs t u d yd e s i g ni st h a th a l fo ft h e
patients receive radiation of the 3D-scan, while they
cannot benefit from this 3D-scan. Because of the rela-
tively low radiation dose of the 3D-scan, this disadvan-
tage is considered acceptable.
An alternative, more pragmatic, study design would
randomize between two operative strategies: with or
without intra-operative 3D- i m a g i n g .I nt h i sd e s i g nn o
patient would receive unbeneficial radiation doses and
this set-up will probably be a better reflection of the
clinical practice. However, comparing two surgical stra-
tegies does not allow the assessment of any missed
incongruences when using 2D-fluoroscopy alone. In
addition, when the surgeonk n o w sh ec a ne m p l o yt h e
3D-imaging strategy, he might change his attitude
towards 2D-fluoroscopy and be less accurate. Hence,
more bias will be introduced because of the surgeon’s
attitude towards 3D-imaging. In addition, 3D-imaging
may also detect incongruences that are corrected, but
may not have any influence on functional outcomes or
long-term development of posttraumatic osteoarthritis.
This possible overdiagnosing with 3D-imaging cannot
be detected with a pragmatic design.
The choice for our study design induced some practi-
cal drawbacks, i.e. the blinding of the 3D-scan for the
surgeon needs some discipline as the only way to blind
the 3D-scan is to turn the screens from the surgeon. In
addition this design warrants more administration dur-
ing surgery because the surgeon evaluates the radiologi-
cal results after every imaging modality. Because of the
use of a secured internet module, this administration is
relatively simple.
Methods/design
Objectives
The objectives of this randomized clinical trial are to:
1. Assess the quality of fracture reduction and fixation
based on the postoperative CT-scans of the ankle, calca-
neus, or wrist, determined by a standard scoring
protocol
2. Assess the patient relevant outcomes
3. Assess the diagnostic value of an intra-operative
3D-RX-scan in a clinical setting
4. Perform a cost-effectiveness analysis to assess
whether the use of 2D-fluoroscopy and the 3D-RX-scan
eventually results in cost savings or is compensated for
by increased health benefits in comparison with the use
of 2D-fluoroscopy only
Study population
The study population consists of adult patients with a
traumatic intra-articular fracture of the wrist, ankle or
calcaneus in which operative treatment is indicated.
Inclusion criteria are:
￿ Adult patients (age > 17 years)
￿ Distal radius fracture, AO-classification A2-C3, or
￿ Distal tibial fracture, AO-classification B1-C3, or
￿ Malleolar fractures, AO-classification A1-C3, or
￿ Calcaneal fractures, Sanders classificationI-IV
￿ Fracture surgery (ORIF or CRIF) required (i.e. intra-
articular fractures with dislocation).
Only intra-articular fractures will be included in this
trial, because the additional value of intra-operative 3D-
imaging is to be expected in these types of fractures. The
complexity of these fractures warrants more insight in
the fracture fragments and fixation material than in
extra-articular fractures. It is debatable whether the distal
radius fractures AO-classification A2-3 and malleolar
fractures C1-3 are true intra-articular fractures. Since we
are interested in the congruence of the distal radioulnar
joint (DRUJ) and the tibiofibular syndesmosis, these frac-
ture types will be included. Especially in these fracture
types, 3D-imaging can give more insight in rotation or
subluxation of the ulna or fibula in these articulations.
Exclusion criteria are:
￿ Pathological fractures, i.e. due to underlying malig-
nant disorder
￿ Rheumatoid osteoarthritis
￿ No written informed consent
￿ Inability to understand trial features due to mental
handicap or language problems
￿ Pregnancy
Study design
The EF3X-trial is an international randomized multicen-
ter trial, with participation of 4 hospitals (3 university
hospitals and 1 regional hospital). Patients eligible for
operative treatment of their intra-articular fracture of
the wrist, ankle or calcaneus will be randomized after
the surgeon is satisfied with the reduction and fixation
after 2D-imaging. Patients will be blinded for the avail-
ability of the 3D-scan.
When operative treatment is indicated in patients pre-
senting to the Emergency Department (ED) with an
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they will be counselled and asked for informed consent
if the in- and exclusion criteria are met.
During surgery, initially only 2D-fluoroscopy is used
for the intra-operative imaging as part of the usual
intra-operative diagnostic procedure (Figure 1). The sur-
geon will then operate until (s)he is satisfied with frac-
ture reduction and fixation. Then the surgeon will be
asked to evaluate the conclusive 2D-images according to
the scoring protocol for anatomical reduction and fixa-
tion, which is developed in the AMC. After this evalua-
tion a 3D-RX-scan will be performed and randomization
will take place.
The randomization will determine whether or not the
information of the 3D-scan will be made available to the
surgeon. Randomization is performed by an internet
randomization module prepared by the AMC Clinical
Research Unit. Block randomization is used and rando-
mization will be stratified for the fractured joint (wrist,
ankle or calcaneus) and participating centre. Since it is
not possible to blind the surgeon, randomization takes
place after the surgeon has finished operating based on
the information of 2D-fluoroscopy and is ready to close
the wound. In this way (s)he cannot anticipate on the
likeliness (s)he gets extra information of the 3D-scan.
Patients will not be informed about whether or not the
3D-scan was made available to the surgeon.
If the 3D-scan results will not be made available, the
surgeon terminates the procedure. If the information of
the 3D-scan is available to the surgeon he can act on the
findings and, if necessary, surgical corrections can be
made. If the surgeon is now satisfied with the operation
result conclusive 2D-fluoroscopic images and a conclu-
sive 3D-scan must be performed. The conclusive 3D-
scan needs to be evaluated according to the scoring pro-
tocol for anatomical reduction. In both randomization
groups a CT-scan will be performed postoperatively.
The follow-up visits after hospital discharge will be
planned at 6 and 12 weeks and 1, 2 and 5 years
postoperatively.
Primary and secondary endpoints
Our primary outcomes are the quality of fracture reduc-
tion and fixation based on the postoperative CT-scans
of the wrist, ankle or calcaneus. This will be determined
by 3 independent experts. These experts will systemati-
cally evaluate the postoperative CT-scans according to a
standard scoring protocol. After this evaluation the
images will be classified as optimal or suboptimal. A
suboptimal reduction and/or fixation will be defined as
Figure 1 Flow chart of the EF3X-trial.
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tic evaluation. In addition, this classification will be
based on the radiological images alone. Patient related
factors, like swelling of the soft tissue will not be taken
into account in this evaluation of a (sub)optimal quality
of fracture reduction and/or fixation.
A standard scoring protocol for the radiological eva-
luation will be developed for each joint separately.
Although scoring protocols for the wrist, ankle and cal-
caneus have been described in the literature, most of
them lack clinical sensitivity, and are therefore infre-
quently used [18]. Another reason for not using these
scoring protocols is that they merely consist of assess-
ment of distance and angle measurements that have a
high interobserver variance and are infrequently used in
clinical practice [19-23]. The scoring protocols we devel-
oped are based on a Delphi consensus on how to evalu-
a t et h ed i f f e r e n tj o i n t s .F o rt h ew r i s ta n da n k l et h i s
Delphi consensus was performed in the Netherlands
[24]. A Delphi consensus for the calcaneus is currently
being performed with international experts.
Second, the patient-relevant outcomes like functional
outcome measured by joint specific questionnaires
(Patient Rated Wrist Evaluation for the wrist and Foot
and Ankle Outcome score and AOFAS for the ankle
and calcaneus) will be determined. The patient relevant
outcomes one year postoperative will be used as end-
points. Patient relevant outcomes determined at 2 and 5
years postoperatively will be used for a follow up study
for the prevalence of posttraumatic osteoarthritis.
Before ending the operation, conclusive 2D-fluoro-
scopic images and a conclusive 3D-RX-scan are being
performed. Together with the postoperative CT-scan
(reference test) these radiologic images all represent the
final operating result. Therefore the diagnostic value of
only the conclusive 2D-fluoroscopic images and 3D-RX-
scan will be determined. This will be done for the wrist,
ankle and calcaneus separately. Hereby the detection of
a suboptimal result, as described above, on the 2D-
fluoroscopic images and/or 3D-RX-scan will be com-
pared to the postoperative CT-scans.
A cost-effectiveness analysis will be performed to
assess the relative benefit from a societal perspective of
the use of the 3D-RX-scan in addition to 2D-
fluoroscopy.
Our secondary study outcomes are:
> The number and type of corrections made after
2D-fluoroscopy
> The number and type of corrections made after a
3D-scan
> The number of revision operations within 30 days
> The number and type of complications within 30
days
> The length of the hospital stay expressed in days
> The quality of life measured by the SF-36
Participating centers
Four centers will enrol patients. Three of these hospitals
are Dutch and one University hospital in California is
willing to participate. The three Dutch hospitals will
consist of 1 regional teaching hospital and two Univer-
sity hospitals. One of the university hospitals, the Aca-
demic Medical Center has already started patient
recruitment and has included 125 patients in a 15-
month period. The other Dutch University hospital, the
University Medical Center Utrecht, will start recruiting
patients in the summer of 2011 and is also expected to
recruit 8-9 patients a month in average. The University
hospital in California expects to recruit 50 patients in a
one year period. In the regional teaching hospital, the
Antonius Hospital in Nieuwegein, approximately 100-
150 patients with a wrist, ankle or calcaneus fractures
are operated upon yearly. Because this hospital has dif-
ferent locations, for logistic reasons it is not possible to
recruit al these patients. It is expected that 75% of these
patients will participate in this trial.
Study outline
Recruitment
Patients will be recruited if they are eligible for operative
treatment of their intra-articular fracture of the wrist,
ankle or calcaneus. This can be at the Emergency
Department (ED), the outpatient clinic or the inpatient
clinical wards of orthopaedic or trauma surgery. After
patients are counselled and informed consent is
obtained, they can be included in the study.
Intra-operative 3D-scan
For this study the BV Pulsera with 3D-RX (3 Dimen-
sional Rotational X-ray) is used. The BV Pulsera (Philips
Healthcare, Best, the Netherlands) consists of a mobile
C - a r mu n i tm o d i f i e dt op r o v i d eam o t o r i z e dr o t a t i o n a l
movement and is combined with a Philips 3D-RA work-
station. A series of 251 projection images is acquired
over a period of 30 seconds during a 200° rotation of
the C-arm. The projection images are used to recon-
struct a 3D data set. Both volume rendering and slice
images are available. The images can be enhanced by
colouring the metal present in the joint (Titanview).
The radiation exposure of each image in the scanning
run is dynamically adjusted to provide the best combi-
nation of low dose and optimal image quality. The
device is continuously available for the duration of this
trial.
Radiation dose
Patients with a fractured wrist, ankle, or calcaneus will
receive an expected maximum of two 3D-RX-scans,
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maximum equivalent dosage of a 3D-RX-scan of the
extremities is 17 μSv. Therefore the additional dosage
during the OR of two exams is in the order of 34 μSv.
Together with the X-rays performed postoperatively, the
radiation dose will approximate 50 μSv. The effective
dose of the postoperative CT-exam (120 kV, 150 mAs)
will not exceed 0,2 mSv. The total dosage for all radio-
graphic exams performed as part of this trial will there-
fore be less than 0,25 mSv. A similar effective dose is
included in category IIa (0,1-1 mSv) of the ICRP (report
ICRP62), which is qualified as a “minor” risk.
Sample size calculation
Based on the available literature, the frequency of sub-
optimal fracture reduction is 18-26%. Research in our
hospital showed a frequency of 17% (Weide vd, A,
Haverlag R, Goslings JC. Inconsistencies in the radio-
graphic analysis of intra-articular fractures. Submitted).
We anticipate that a suboptimal fracture reduction and/
or fixation will occur in 5% of the patients, when using
the 3D-RX-system, as described by Kendoff et al.[25] To
be able to detect this difference of 12% using a two-
group continuity corrected Chi-square test at an a =
0.05 and a power of 0.80, we will need to include 122
patients per randomization group. To account for an
approximately 3% dropout by technical or logistic fail-
ures of the 3D-RX-system, a total of 250 patients have
to be included for each fracture type.
Because of possibly differential results, patients will be
stratified into three groups:
1. Patients with wrist fractures will include distal
radius fractures, AO-classification A1-C3
2. Patients with ankle fractures will include distal tibial
fractures, AO-classification B1-C3 and malleolar frac-
tures, AO-classification A1-C3
3. Patients with calcaneal fractures will include San-
ders classification I-IV
A total of 750 patients will be included in this trial, i.e.
250 for each fracture type.
Data collection
Pre-operatively baseline data of the patient and fracture
type are collected. Intra-operatively the surgeon will be
asked to evaluate the operated joint according to the
scoring protocol for anatomical reduction and fixation,
which is developed in the AMC. If the 3D-scan is avail-
able to the surgeon (s)he will evaluate the 3D-scan
intra-operatively according to the scoring protocol men-
tioned above.
During the follow-up visits at 6 and 12 weeks and 1, 2
and 5 years postoperatively the range of motion, func-
tional outcome and strength of the operated joint will
be recorded and compared to the contralateral joint. For
wrist fractures the ‘Patient rated Wrist Evaluation’
(PRWE) score will be used, for ankle and calcaneus frac-
tures the ‘Foot and Ankle Outcome Score’ (FAOS) will
be assessed. Quality of life will be determined by the SF-
36. These are validated outcome scores. In addition a
questionnaire pertaining questions on work-related
items and the patients indirect costs of production loss
will be assessed.
All intra-operative images (both 2D-fluoroscopy and
3D-scans) and postoperative CT-scans will be evaluated
by 3 independent experts in blinded fashion and random
order according to a standard scoring protocol. These
experts will consist of 2 trauma/orthopedic surgeons
and a radiologist. Data collected by the physicians will
be entered in a secured Internet module which is spe-
cially designed for the EF3X-trial. Patients will be given
the choice to receive digital or paper questionnaires.
Collection of data and questionnaires will be safe-
guarded by the trial coordinator.
Data monitoring
Because of the size of the trial it was considered impor-
tant to ensure independent review. Therefore a Data
Monitoring Committee (DMC) is set up to ensure the
safety of the study participants, provide independent
review of safety, ensure the integrity of the study conduct
and results and review of the formal interim analysis.
Data analysis
All analyses will be performed in accordance with the
intention to treat principle.
The primary outcome, the quality of fracture reduc-
tion as well as the quality of fixation will be classified as
optimal or suboptimal. This dichotomous outcome, will
be described as a percentage in both groups. Differences
between study groups will be analysed by means of a
Chi-square test. A p-value < 0.05 will be taken as the
threshold for statistical significance.
The scores of the functional outcomes determined by
joint specific questionnaires at 1 year postoperative will
be expressed as means and standard deviations (SD) in
case of a normal distribution. Non-normally distributed
outcomes will be expressed as medians and interquartile
ranges. Normality of continuous data will be tested with
the Shapiro-Wilk and Kolmogorov-Smirnov test and by
inspecting the frequency distributions (histograms). The
homogeneity of variances will be tested using the
Levene’s test. The functional outcomes will be assessed
using the Student’s T-test (parametric data) or the
Mann-Whitney U-test (non-parametric data). Differ-
ences will be considered statistically significant when P-
values are < 0.05.
T h ed i a g n o s t i ca c c u r a c yo fas u b o p t i m a lq u a l i t yo f
fracture reduction and/or fixation will be determined for
Beerekamp et al. BMC Musculoskeletal Disorders 2011, 12:151
http://www.biomedcentral.com/1471-2474/12/151
Page 6 of 9reduction and fixation for the wrist, ankle and calcaneus
separately. Sensitivity, specificity, positive and negative
predictive values for both 2D-fluoroscopy and the 3D-
RX-scan will be calculated with the corresponding 95%
confidence intervals for the classification of an optimal
or suboptimal result as described above. This will be
determined for both 2D-fluoroscopy and the 3D-RX-
scan with the postoperative CT-scan as reference
standard.
The number of patients in which corrections were
performed intra-operatively after 2D-fluoroscopy or the
3D-RX-scan will be described as percentages. Differ-
ences between study groups will be analysed by means
of a Chi-square test. The same analysis will be done for
the number of patients with a revision operation or
complication within 30 days. The length of hospital stay
will be expressed as medians and interquartile ranges,
and differences between groups will be analysed using a
Mann-Whitney U test. The quality of life measured by
the SF-36 will be expressed as means and standard
deviations (SD) after testing for normal distribution and
compared between groups using an unpaired Student t-
test. For all secondary parameters a p-value < 0.05 will
be taken as the threshold for statistical significance.
Economic evaluation
T h ee c o n o m i ce v a l u a t i o no fi n t r a - o p e r a t i v eu s eo f3 D -
RX against the use of 2D-fluoroscopy as its best alterna-
tive will be performed from a societal perspective as
both, a cost-effective and a cost-utility analysis. As the
costs of a 3D-RX-system are 1,5 times the costs of a
standard C-arm and there is the risk of over diagnosing,
an economic evaluation is warranted. This cost-effec-
tiveness analysis is chosen to comply with the clinical
endpoint and enables assessment of diagnostic strategies
and therapeutic interventions within the field of joint
trauma care. The cost-utility analysis is chosen to enable
comparisons between the currently proposed optimiza-
tion of health care (3D versus 2D imaging) on the one
hand and new developments and technologies for other
diseases and in other areas of medicine on the other
hand. The primary outcomes will be the costs per
patient with optimal fracture reduction (at 12 weeks
post index operation, thus including assessments of re-
interventions) and the costs per QALY respectively. The
time horizon will be 12 weeks following the index
operation. With this length of the follow-up period no
discounting of costs will take place.
Incremental cost-effectiveness and cost-utility ratios
will be calculated for the extra costs per extra patient
with optimal fracture reduction and the extra costs per
QALY gained. Univariable and multivariable sensitivity
analyses will be applied for unit costs of 3D-scan and
country-specific health utility value sets (see below). Bias
corrected and accelerated bootstrapping will be done to
account for sampling variability. All analyses will be
done for each subgroup of patients (with wrist, ankle or
calcaneus fracture respectively).
The costs will include the direct medical and non-
medical as well as the indirect non-medical costs of
care. The direct medical costs include the costs of diag-
nostics, surgery, in-patient stay, and out-of-hospital care
postdischarge (e.g. family practitioner, physiotherapist,
rehabilitation care). Also, out-of-pocket expenses of
patients will be quantified (over-the-counter medication,
private help at home, etc.). The indirect non-medical
costs of production loss due to work absenteism will
also be calculated. Principally, the friction cost method
will be applied to quantify these production losses (in
practice though, the length of the friction period at the
time of analysis presumably will be longer than the
planned follow-up period of patients). Volume data on
health care resource use, out-of-pocket expenses and
work absenteism will be gathered with case report
forms, hospital information systems, and a patient ques-
tionnaire, partially based on the Health and Labour
questionnaire [26]. Unit costs will derive from the
national guideline on costing in health care research
[27]. Unit costs will be price-indexed to derive cost esti-
mates for the base year 2011.
Fractures can be quite disabling in daily life. In addi-
tion to the already mentioned general (SF-36) and
domain-specific (FAOS, PRWE) quality of life question-
naires, the EQ-5D will be applied as a health utility
instrument for use in the cost-utility analysis. The health
status scoring profiles gathered with the EQ-5D will be
transformed into health utilities using available time
trade-off based valuation algorithms from the literature.
Initially, the Dutch valuations will be used [28]. In a
sensitivity analysis the internationally more frequently
applied algorithm from the UK will be applied [29].
Early experience from the ongoing trial
During a period of 15 months 125 patients have been
included in one hospital alone. Next to recruitment of
patients in the Academic Medical Center (AMC),
recruitment will also start in the St. Antonius hospital
in Nieuwegein and the University Medical Center
Utrecht in the Netherlands. Internationally the Univer-
sity of California San Francisco Medical Center will par-
ticipate. Patient recruitment in the AMC has gone
according to expectations and there are few patients not
willing to participate. Due the acute nature of fracture
surgery some patients are not able to be counselled and
therefore excluded from participation.
For the clinical follow up it appears that 6 weeks post-
operative is too early to fill in the selfreported joint-spe-
cific questionnaires. Most patients have had 6 weeks of
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Page 7 of 9cast immobilisation and have not performed the activ-
ities questioned or were advised not to perform some of
the activities. For this reason most patients leave some
answers blank. Most of the questionnaires filled in after
12 weeks and 1 year postoperatively are filled in cor-
rectly and will be used as an endpoint for the clinical
outcome.
Discussion
Intra-operative 3D-imaging in fractures of the extremi-
ties has been introduced a decade ago. Several cadaver
studies have been performed to determine the diagnostic
value of 3D-imaging, showing that it is comparable to
CT-scanning. Clinical studies have shown that extra cor-
rections in 11-30% are performed when using additional
3D-imaging during fracture surgery. Still the effective-
ness of the corrections mentioned before on the quality
of fracture reduction and fixation and patient relevant
outcomes has not yet been determined. The EF3X-trial
aims to provide evidence based answers on the effective-
ness of the intra-operative use of 3D-imaging intra-
articular fractures of the extremities.
This trial compares the use of additional 3D-imaging
in surgical treatment of intra-articular fractures of the
extremities. Although it is widely accepted to strive for
anatomical fracture reduction and fixation, there’s still
little evidence to support this. Therefore, in addition to
the short-term radiological endpoint, also the long-term
patient relevant outcomes will be determined in this
trial.
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